XML 50 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
5 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from Operating Activities:        
Net income (loss) $ (310) $ 104,183 $ 391,293 $ (487,989)
Formation costs paid by related party 310      
Adjustments to reconcile net income to net cash used in operating activities:        
Increase (decrease) in fair value of warrants   (1,675,000) (800,000) (475,000)
Interest earned on marketable securities held in Trust Account   (342,986) (5,084) (6,299)
Changes in current assets and current liabilities:        
Prepaid expenses   10,611 (126,319) (71,319)
Accrued offering costs and expenses   1,152,511 10,156 325,641
Income tax payable   8,083 0  
Due to related party   90,000 81,643 111,643
Net cash used in operating activities   (652,598) (448,311) (603,323)
Cash Flows from Investing Activities:        
Purchase of investment held in Trust Account   0 (57,500,000) (57,500,000)
Net cash used in investing activities   0 (57,500,000) (57,500,000)
Cash flows from Financing Activities:        
Proceeds from Initial Public Offering, net of underwriters' fees   0 56,350,000 56,350,000
Proceeds from private placement   0 2,500,000 2,500,000
Proceeds from issuance of promissory note to related party 80,000 399,380 0  
Repayment of promissory note to related party   0 (80,000) (80,000)
Payments of offering costs (54,575) 0 (317,910) (362,910)
Net cash provided by financing activities 25,425 399,380 58,452,090 58,407,090
Net change in cash 25,425 (253,218) 503,779 303,767
Cash, beginning of the period 0 329,192 25,425 25,425
Cash, end of the period 25,425 75,974 529,204 329,192
Supplemental disclosure of noncash investing and financing activities:        
Deferred offering costs paid by Sponsor in exchange for issuance of common stocks 25,000      
Fair value of representative shares included in deferred offering costs $ 2,000      
Initial value of Common stock subject to possible redemption   0 50,150,000 50,150,000
Remeasurement in value of Common stock subject to possible redemption   28,802 7,355,084 7,350,000
Initial fair value of warrant liabilities   $ 0 $ 2,450,000 $ 2,450,000